Itraconazol Alter (Itraconazole)

Itraconazole blocks the fungal enzyme lanosterol 14α‑demethylase, which is required for converting lanosterol to ergosterol, a key component of the fungal cell membrane. Inhibiting this step disrupts membrane formation, leading to impaired fungal growth and eventual cell death.

The dosage of Itraconazol Alter is individualized by the prescribing clinician according to the type and severity of the infection, patient weight, renal and hepatic function, and other clinical factors. Patients should follow the exact regimen provided by their healthcare provider.

Safety data for itraconazole in pregnancy and lactation are limited, and the product is classified as pregnancy category unknown. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified prescriber.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity of Itraconazol Alter. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Itraconazol Alter belongs to the triazole class, offering a broad spectrum against yeasts and molds. Compared with older azoles like fluconazole, itraconazole has enhanced activity against certain molds (e.g., Aspergillus) and dimorphic fungi, but may have a higher potential for drug‑drug interactions due to CYP3A4 inhibition.

Store Itraconazol Alter at ambient temperature, below 25 °C, in the original packaging. Protect the product from moisture, excessive heat, and direct sunlight to maintain its stability and potency throughout its shelf life.

Itraconazol Alter is taken orally, usually with a full glass of water. Depending on the formulation, it may be recommended to take the medication with food to improve absorption, but patients should follow the specific instructions given by their prescriber.

Serious risks include hepatotoxicity, severe allergic reactions such as anaphylaxis, cardiac failure in susceptible individuals, QT‑interval prolongation leading to arrhythmias, and rare but life‑threatening skin reactions like Stevens‑Johnson syndrome. Patients should be monitored regularly for these events.

Itraconazol Alter should be avoided in patients with known hypersensitivity to itraconazole or any component of the formulation, those with severe liver impairment, and individuals taking medications that have a contraindicated interaction, such as strong CYP3A4 inducers like rifampin, unless alternative therapy is not feasible.